[Heparin-induced thrombocytopenia: the clinical picture and treatment].
Matsuo
Takefumi
T
D000925:Anticoagulants / Q000009:adverse effects*; D001120:Arginine / Q000031:analogs & derivatives; D001323:Autoantibodies / Q000097:blood; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D010875:Pipecolic Acids / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*
D000925:Anticoagulants; D001323:Autoantibodies; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban